Stockscreener 앱 받기
7.02
2.09%
-0.15
시간 외 거래:
7.03
0.01
+0.14%
Organon Co 주식(OGN)의 최신 뉴스
Organon Launches Phase 3 Study on Tapinarof Cream for Atopic Dermatitis in Infants - TipRanks
Why Analysts See Organon’s Story Shifting Amid Governance Concerns And Lower Valuations - Yahoo Finance UK
Is Trending Stock Organon & Co. (OGN) a Buy Now? - Yahoo Finance
Organon & Co. $OGN Stake Lessened by Globeflex Capital L P - MarketBeat
Organon Shares Under Pressure Following Critical Analyst Review - AD HOC NEWS
Can Organon’s Steep 2025 Share Price Slide Signal a Long Term Opportunity? - simplywall.st
Organon pushes bold women’s health agenda at WHX Leaders’ Summit in Accra - MyJoyOnline
Les billets sont maintenant en vente pour Importance Vitale : sommet national sur la santé des femmes - GlobeNewswire Inc.
Why Organon (OGN) shares are trading lower today - MSN
New York State Common Retirement Fund Sells 353,330 Shares of Organon & Co. $OGN - MarketBeat
Understanding Momentum Shifts in (OGN) - news.stocktradersdaily.com
Investors in Organon & Co. (OGN): Protect Your RightsContact Levi & Korsinsky Before July 22, 2025 - ACCESS Newswire
Organon & Co. (NYSE:OGN) Stock Rating Upgraded by Barclays - MarketBeat
Organon & Co. $OGN Shares Bought by Cerity Partners LLC - MarketBeat
WHX Africa Leaders Summit: Organon Unveils Multi-Sector Approach to Women’s Health in Africa - News Ghana
Barclays Initiates Coverage of Organon (OGN) with Underweight Recommendation - Nasdaq
Why Organon (OGN) Shares Are Trading Lower Today - The Globe and Mail
Organon (OGN) Receives New Coverage with 'Underweight' Rating fr - GuruFocus
Barclays Initiates Coverage on Organon & Co. (NYSE:OGN) - MarketBeat
Norges Bank Takes $19.78 Million Position in Organon & Co. $OGN - MarketBeat
Organon initiated with an Underweight at Barclays - TipRanks
American Century Companies Inc. Grows Position in Organon & Co. $OGN - MarketBeat
What analysts say about Organon Co stockFederal Reserve Announcements & Outstanding Growth Strategies - earlytimes.in
A Closer Look At Organon & Co.'s (NYSE:OGN) Impressive ROE - 富途牛牛
Can Organon (OGN) Turn Rising Investor Attention Into a Durable Reboot of Its Core Story? - simplywall.st
Organon & Co. (OGN) Stock Forecasts - Yahoo! Finance Canada
Co. (7XP) stock compared to peersPortfolio Update Report & Precise Buy Zone Identification - Newser
Organon & Co. $OGN Shares Acquired by Brandes Investment Partners LP - MarketBeat
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - MSN
Russell Investments Group Ltd. Has $15.96 Million Stock Position in Organon & Co. $OGN - MarketBeat
Can Organon’s (OGN) Biosimilar Push Transform Its Competitive Position in US Oncology? - Yahoo Finance
A Look at Organon's Valuation Following FDA Approval of First US Pertuzumab Biosimilar - Yahoo Finance
Is Organon’s Recent 14% Price Jump Justified After Women’s Health Partnership News? - Yahoo Finance
What analysts say about Organon Co 7XP stockShort Interest Overview & Grow Steadily With Our Wealth Roadmap - earlytimes.in
Organon (OGN): Buy, Sell, or Hold Post Q3 Earnings? - The Globe and Mail
Grantham Mayo Van Otterloo & Co. LLC Buys 108,429 Shares of Organon & Co. $OGN - MarketBeat
Avoiding Lag: Real-Time Signals in (OGN) Movement - news.stocktradersdaily.com
Organon (OGN): Exploring Valuation Following FDA Approval of First US Pertuzumab Biosimilar - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Organon & Co. $OGN Shares Sold by Envestnet Asset Management Inc. - MarketBeat
Organon & Co. (OGN) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
Creative Planning Buys 97,429 Shares of Organon & Co. $OGN - MarketBeat
Advisors Asset Management Inc. Sells 64,625 Shares of Organon & Co. $OGN - MarketBeat
Is Organon Co 7XP a good long term investmentLong-Term Investment Plans & High Yield Investment Portfolio - earlytimes.in
Organon & Co. $OGN Shares Sold by Geode Capital Management LLC - MarketBeat
Q3 Rundown: Organon (NYSE:OGN) Vs Other Branded Pharmaceuticals Stocks - The Globe and Mail
EXTENDED CLASS PERIOD: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit (PR Newswire) - Aktiellt
TUESDAY INVESTOR DEADLINE: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit (PR Newswire) - Aktiellt
Congressional Trading Report: Sen. Gary C Peters Sold Over $1K In Organon Stock - Sahm
Organon (NYSE: OGN) leaders to speak at Piper Sandler 37th Annual Healthcare Conference - Stock Titan
Organon & Co.Gary C. Peters Congressional Trade on Jul. 10, 2025 - Quiver Quantitative
Organon’s Deep Discount Comes With a Heavy Dose of Risk - Finimize
Can OGN’s First US Biosimilar Approval Redefine Its Long-Term Oncology Strategy? - Sahm
1.77%
2.24%
자본화:
|
볼륨(24시간):